Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MDM2 |
Variant | M62V |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | MDM2 M62V lies within the TP53-binding domain of the Mdm2 protein (PMID: 14707282). M62V has been shown to confer MDM2 inhibitor resistance in cell culture (PMID: 23653682), but has not been biochemically characterized and therefore, its effect on Mdm2 protein function is unknown (PubMed, Nov 2023). |
Associated Drug Resistance | Y |
Category Variants Paths |
MDM2 mutant MDM2 M62V |
Transcript | NM_001367990.1 |
gDNA | chr12:g.68816839A>G |
cDNA | c.184A>G |
Protein | p.M62V |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001145337.2 | chr12:g.68816839A>G | c.184A>G | p.M62V | RefSeq | GRCh38/hg38 |
NM_001145337.3 | chr12:g.68816839A>G | c.184A>G | p.M62V | RefSeq | GRCh38/hg38 |
XM_005268872.5 | chr12:g.68816839A>G | c.184A>G | p.M62V | RefSeq | GRCh38/hg38 |
XM_005268872 | chr12:g.68816839A>G | c.184A>G | p.M62V | RefSeq | GRCh38/hg38 |
NM_001145337 | chr12:g.68816839A>G | c.184A>G | p.M62V | RefSeq | GRCh38/hg38 |
NM_001367990.1 | chr12:g.68816839A>G | c.184A>G | p.M62V | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
MDM2 M62V | Advanced Solid Tumor | predicted - resistant | Nutlin-3a | Preclinical - Biochemical | Actionable | In a preclinical study, MDM2 M62V conferred partial resistance to Nutlin-3a as demonstrated by decreased restoration of Tp53 activity in reporter assays in culture, and impaired inhibition of Mdm2-Tp53 interaction in in vitro assays (PMID: 23653682). | 23653682 |